Pharmacology and IV Therapy Fundamentals

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/29

flashcard set

Earn XP

Description and Tags

These flashcards cover drug nomenclature, federal legislation and schedules, the stages of new drug development, and intravenous therapy equipment and complications.

Last updated 3:01 AM on 6/16/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

30 Terms

1
New cards

Biosimilar

A biologic product that is close in structure and function to an existing approved biologic product.

2
New cards

The United States Pharmacopeia (USP)/National Formulary (NF)

The official source for American drug standards.

3
New cards

Federal Food, Drug, and Cosmetics Act (1938)

A primary piece of US drug legislation enacted in 1938.

4
New cards

Contaled Substance Art (1970)

Defined 5 classifications/schedules of controlled substances.

5
New cards

Schedule 1 Controlled Substance

High abuse potential with no medical use; include examples like heroin and cocaine.

6
New cards

Schedule 2 Controlled Substance

High abuse potential with some medical use, such as pentobarbital.

7
New cards

Schedule 3 Controlled Substance

High abuse potential with some medical use, such as codeine.

8
New cards

Schedule 4 Controlled Substance

Low abuse potential with some medical use, such as diazepam.

9
New cards

Schedule 5 Controlled Substance

Low abuse potential where a prescription is not needed, such as Robitussin.

10
New cards

Preclinical research phase

The first stage of new drug development; involves research and development and commonly takes 18months18\,\text{months}.

11
New cards

Clinical Research and development

The second stage of drug development; can take up to 10years10\,\text{years} but commonly lasts 5years5\,\text{years}.

12
New cards

New Drug Application (NDA) Review

The third stage of drug development, which lasts an average of 17months17\,\text{months}.

13
New cards

Post-marketing Surveillance

The fourth stage of drug development used to see if the drug is effective and functioning as desired.

14
New cards

Drugs

Chemical substances that have an effect on living organisms.

15
New cards

Biologic Therapy

A new class of drugs consisting of large, complex proteins manufactured in a living system to treat disorders attacking the body's own organs, tissues, and cells.

16
New cards

Chemical Name

Significant to chemists to understand the make-up of a drug.

17
New cards

Generic Name

The official name listed by the FDA; not capitalized and used by formularies.

18
New cards

Brand or Trademark Name

The name registered by manufacturers, which is always capitalized.

19
New cards

Intracellular Compartment

The fluid compartment located inside cells.

20
New cards

Intravascular Compartment

The fluid compartment including blood vessels, arteries, and capillaries.

21
New cards

Interstitial Compartment

The fluid compartment located between cells.

22
New cards

Macrodrip

A drip chamber that delivers 1010, 1515, or 20drops/mL20\,\text{drops/mL}.

23
New cards

Microdrip

A drip chamber that delivers 60drops/mL60\,\text{drops/mL}.

24
New cards

Formula for drops/min

mL of SolutionHours of admin×Drops (drip factor)60mins=drops/min\frac{\text{mL of Solution}}{\text{Hours of admin}} \times \frac{\text{Drops (drip factor)}}{60\,\text{mins}} = \text{drops/min}

25
New cards

Peripheral Access Devices

Devices for short-term use in peripheral veins of the hand or forearm.

26
New cards

Midline Catheters

Catheters inserted into intermediate-sized veins and advanced into larger vessels.

27
New cards

Central Access Device Sites

Typically established in the subclavian, jugular, or femoral veins.

28
New cards

Implantable Infusion Ports

Used for long-term therapy in central veins; accessed with a 9090^\circ Huber needle.

29
New cards

Tunneled central venous catheters

Surgically placed catheters where the proximal end exits on the chest.

30
New cards

IV Complications

Includes phlebitis, thrombophlebitis, infection, septicemia, infiltration, extravasation, air embolus, circulatory overload, pulmonary edema, pulmonary embolism, and speed shock.